Naz Rahman
Stock Analyst at Maxim Group
(0.11)
# 4,626
Out of 4,692 analysts
473
Total ratings
38.8%
Success rate
-6.4%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XTNT Xtant Medical Holdings | Reiterated: Buy | $1.5 | $0.392 | +282.65% | 3 | Aug 28, 2026 | |
| NXGL NEXGEL | Downgraded: Hold | n/a | $0.3588 | - | 34 | Aug 24, 2026 | |
| SLXN Silexion Therapeutics | Maintained: Hold | n/a | $0.3697 | - | 25 | Aug 19, 2026 | |
| VANI Vivani Medical | Reiterated: Buy | $4 | $1.39 | +187.77% | 28 | Aug 18, 2026 | |
| CLNN Clene | Reiterated: Buy | $20 | $4.28 | +367.29% | 34 | Aug 18, 2026 | |
| SCNX Scienture Holdings | Reiterated: Buy | $1.5 | $0.3885 | +286.10% | 4 | Aug 17, 2026 | |
| ACOG Alpha Cognition | Reiterated: Buy | $12 | $9.27 | +29.45% | 3 | Aug 17, 2026 | |
| CING Cingulate | Reiterated: Buy | $8 | $5.17 | +54.74% | 28 | Aug 14, 2026 | |
| TLPH Talphera | Reiterated: Buy | $3 | $1.19 | +152.10% | 14 | Aug 13, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $1.95 | +310.26% | 32 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $575 | $544.52 | +5.60% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.73 | +31.98% | 15 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $32.78 | +113.54% | 38 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 → €12.00 | €3.95 | +203.80% | 7 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $13.77 | +117.86% | 14 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.22 | +157.23% | 34 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.12 | - | 13 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $2.29 | +205.68% | 20 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.05 | - | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.4267 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.004 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.9536 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.67 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.72 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $9.39 | n/a | 1 | Aug 12, 2021 |
Xtant Medical Holdings
Aug 28, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.392
Upside: +282.65%
NEXGEL
Aug 24, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3588
Upside: -
Silexion Therapeutics
Aug 19, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3697
Upside: -
Vivani Medical
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $1.39
Upside: +187.77%
Clene
Aug 18, 2026
Reiterated: Buy
Price Target: $20
Current: $4.28
Upside: +367.29%
Scienture Holdings
Aug 17, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.3885
Upside: +286.10%
Alpha Cognition
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $9.27
Upside: +29.45%
Cingulate
Aug 14, 2026
Reiterated: Buy
Price Target: $8
Current: $5.17
Upside: +54.74%
Talphera
Aug 13, 2026
Reiterated: Buy
Price Target: $3
Current: $1.19
Upside: +152.10%
Palisade Bio
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $1.95
Upside: +310.26%
Aug 5, 2026
Reiterated: Buy
Price Target: $575
Current: $544.52
Upside: +5.60%
Aug 5, 2026
Reiterated: Buy
Price Target: $30
Current: $22.73
Upside: +31.98%
Jul 31, 2026
Reiterated: Buy
Price Target: $70
Current: $32.78
Upside: +113.54%
Jul 27, 2026
Reiterated: Buy
Price Target: €16.00 → €12.00
Current: €3.95
Upside: +203.80%
Jul 15, 2026
Reiterated: Buy
Price Target: $30
Current: $13.77
Upside: +117.86%
Jul 10, 2026
Reiterated: Buy
Price Target: $16
Current: $6.22
Upside: +157.23%
Jun 10, 2026
Maintained: Hold
Price Target: n/a
Current: $4.12
Upside: -
May 15, 2026
Rated: Buy
Price Target: $7
Current: $2.29
Upside: +205.68%
Nov 19, 2025
Maintained: Hold
Price Target: n/a
Current: $2.05
Upside: -
Aug 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.4267
Upside: n/a
Dec 18, 2024
Maintained: Buy
Price Target: n/a
Current: $0.004
Upside: n/a
Nov 20, 2024
Maintained: Hold
Price Target: n/a
Current: $0.9536
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: n/a
Current: $5.67
Upside: n/a
Jan 13, 2022
Maintained: Hold
Price Target: n/a
Current: $3.72
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $6
Current: $9.39
Upside: n/a